ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Recurrence
Mantle-Cell Lymphoma

Non-Hodgkin Lymphoma trials near Cincinnati, OH, USA:

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...

Enrolling
Refractory B-Cell Non-Hodgkin Lymphoma
B Cell Lymphoma
Genetic: CB-010
Drug: Cyclophosphamide

Phase 1

Caribou Biosciences

Cincinnati, Ohio, United States of America and 37 other locations

chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....

Enrolling
Relapsed Non-Hodgkin Lymphoma
Large B-cell Lymphoma
Drug: Cyclophosphamide
Drug: Fludarabine

Phase 1, Phase 2

Lyell Immunopharma

Cincinnati, Ohio, United States and 26 other locations

ifosfamide, carboplatin, and etoposide (R-ICE) in pediatric and young adult participants with relapsed and refractory (R/R) mature B-cell non...

Enrolling
Mature B-Cell Non-Hodgkin Lymphoma
Drug: Ifosfamide
Drug: Rituximab

Phase 1, Phase 2

Roche
Roche

Cincinnati, Ohio, United States and 27 other locations

CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients with relapsed or refractory large B-cell lymphoma...

Enrolling
Lymphoma, B-Cell
Diffuse Large B Cell Lymphoma Refractory
Biological: axicabtagene ciloleucel
Biological: lisocabtagene maraleucel

Phase 3

Lyell Immunopharma

Cincinnati, Ohio, United States and 38 other locations

The most common types of mature B-cell lymphomas (MBLs) in children are Burkitt lymphoma (BL) and diffuse large B-cell lymphoma...

Active, not recruiting
Non-hodgkin Lymphoma
Drug: Epcoritamab

Phase 1

Genmab
Genmab

Cincinnati, Ohio, United States and 40 other locations

B-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections. The purpose of this stud...

Enrolling
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: ABBV-525

Phase 1

AbbVie
AbbVie

Cincinnati, Ohio, United States and 38 other locations

safety, and pharmacokinetics of mosunetuzumab subcutaneous (SC) formulation in participants with selected B-cell malignancies (types of non-...

Active, not recruiting
Non-Hodgkin Lymphoma
Drug: Mosunetuzumab (Cohorts A-C)
Drug: Mosunetuzumab (Cohorts D-E)

Phase 2

Genentech
Genentech

Cincinnati, Ohio, United States and 40 other locations

This is a Phase 1, open-label, multicenter study. This will be the first-in-human clinical study for ONO-7018 and will be conducted in two phases: a...

Active, not recruiting
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic, B-Cell
Drug: ONO-7018

Phase 1

Ono Pharmaceuticals
Ono Pharmaceuticals

Cincinnati, Ohio, United States and 9 other locations

The study evaluates CLR 131 in children, adolescents, and young adults with relapsed or refractory malignant solid tumors and lymphoma and r...

Active, not recruiting
Pediatric Lymphoma
Osteosarcoma
Drug: CLR 131

Phase 1

Cellectar Biosciences

Cincinnati, Ohio, United States and 7 other locations

Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood ce-...

Enrolling
Hematologic Cancer
Drug: ABBV-101

Phase 1

AbbVie
AbbVie

Cincinnati, Ohio, United States and 50 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems